MBX BiosciencesMBX
那斯達克 · USD
13.75
+0.50
(+3.77%)
收盤 08/02 03:59 (UTC+8)
盤後
14.02
+0.29
(+2.11%)
08/02 03:59 (UTC+8)
MBX BiosciencesMBX
13.75
+0.50
(+3.77%)
財務數據
損益表
- -
- 0.00
- 0.00
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2022/Q4 | |
營業收入淨額 | - | - | - | 0 | 0 | 0 | 0 | - |
營業成本 | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | 0 | 0 | 0 | 0 | - |
營業費用 | 26,529 | 18,610 | 19,612 | 16,658 | 13,314 | 9,991 | 10,945 | 25,161 |
研發費用 | 22,405 | 15,223 | 16,747 | 14,396 | 11,049 | 7,727 | 9,073 | 21,397 |
推銷及管理費用 | 4,124 | 3,387 | 2,865 | 2,262 | 2,265 | 2,264 | 1,872 | 3,764 |
非經常性項目費用 | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - |
營業利益 | -26,529 | -18,610 | -19,612 | -16,658 | -13,314 | -9,991 | -10,945 | -25,161 |
其他收入及費用 | 2,649 | 3,024 | 1,470 | - | - | - | - | -600 |
利息費用 | - | - | - | - | - | - | - | 374 |
稅前純益 | -23,880 | -15,586 | -18,142 | -15,857 | -12,337 | -8,843 | -10,162 | -26,135 |
所得稅 | - | - | - | - | - | - | - | - |
稅後純益 | -23,880 | -15,586 | -18,142 | -15,857 | -12,337 | -8,843 | -10,162 | -26,135 |
基本每股稅後盈餘(元) | -0.71 | -0.47 | -2.78 | - | -0.39 | - | -0.32 | - |
稀釋每股稅後盈餘(元) | -0.71 | 9.60 | 7.51 | - | -0.39 | - | -0.32 | - |
基本平均股數(千股) | 33412.00 | 33392.00 | 6515.00 | - | 31853.00 | - | 31853.00 | - |
稀釋平均股數(千股) | 33412.00 | 33392.00 | 6515.00 | - | 31853.00 | - | 31853.00 | - |
還原基本每股稅後盈餘(元) | -0.71 | -0.47 | -2.78 | - | -0.39 | - | -0.32 | - |
還原稀釋每股稅後盈餘(元) | -0.71 | 9.60 | 7.51 | - | -0.39 | - | -0.32 | - |
還原基本平均股數(千股) | 33,412 | 33,392 | 6,515 | - | 31,853 | - | 31,853 | - |
還原稀釋平均股數(千股) | 33,412 | 33,392 | 6,515 | - | 31,853 | - | 31,853 | - |
EBITDA(千元) | -25,146 | -16,925 | -18,654 | -15,794 | -12,289 | -8,802 | -10,122 | -25,732 |